ArticleJournal for immunotherapy of cancer2024

Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells.

Richard Baugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.